Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leike Li

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Oncotarget|September 2, 2016
Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancerShu Zhang, Seema Mukherjee, Xuejun Fan, et al.
Frontiers in Chemistry|April 19, 2024
Magnetic-driven hydrogel microrobots for promoting osteosarcoma chemo-therapy with synthetic lethality strategyYining Tao, Leike Li, Xiyu Yang, et al.
Antibody Therapeutics|April 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugatesAiko Yamaguchi, Junping Hong, Leike Li, et al.
Science Translational Medicine|September 7, 2022
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's diseasePeng Zhao, Yuanzhong Xu, LuLin Jiang, et al.
Antibody Therapeutics|January 23, 2023
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in miceLeike Li, Yankai Wen, Daniel Wrapp, et al.
NPJ Vaccines|February 21, 2024
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadthHsuan-Yuan Wang, Leike Li, Cody S Nelson, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific AntibodyWeixu Meng, Aimin Tang, Xiaohua Ye, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
NPJ Vaccines|October 10, 2023
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infectionSarah M Valencia, Eric Rochat, Melissa J Harnois, et al.
Ecotoxicology and Environmental Safety|July 27, 2019
Benchmark dose assessment for coke oven emissions-induced telomere length effects in occupationally exposed workers in ChinaWei Wang, Pengpeng Wang, Sihua Wang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Oncotarget|September 2, 2016
Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancerShu Zhang, Seema Mukherjee, Xuejun Fan, et al.
Frontiers in Chemistry|April 19, 2024
Magnetic-driven hydrogel microrobots for promoting osteosarcoma chemo-therapy with synthetic lethality strategyYining Tao, Leike Li, Xiyu Yang, et al.
Antibody Therapeutics|April 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugatesAiko Yamaguchi, Junping Hong, Leike Li, et al.
Science Translational Medicine|September 7, 2022
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's diseasePeng Zhao, Yuanzhong Xu, LuLin Jiang, et al.
Antibody Therapeutics|January 23, 2023
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in miceLeike Li, Yankai Wen, Daniel Wrapp, et al.
NPJ Vaccines|February 21, 2024
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadthHsuan-Yuan Wang, Leike Li, Cody S Nelson, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific AntibodyWeixu Meng, Aimin Tang, Xiaohua Ye, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
NPJ Vaccines|October 10, 2023
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infectionSarah M Valencia, Eric Rochat, Melissa J Harnois, et al.
Ecotoxicology and Environmental Safety|July 27, 2019
Benchmark dose assessment for coke oven emissions-induced telomere length effects in occupationally exposed workers in ChinaWei Wang, Pengpeng Wang, Sihua Wang, et al.
Pageof 4